Skip to main content
FinSpry Logo
FinSpry
JNJ logo
JNJ
(NYSE)
Johnson & Johnson
$259.27-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Johnson & Johnson (JNJ) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Johnson & Johnson stock.

Analyst Consensus Rating

Investment consensus from 25 professional research analysts

Consensus Rating

Buy
Based on 25 unique analysts
(35 total ratings in last 90 days)
Very High Confidence∞:1 Buy/Sell

Average Price Target

$269.94
↑ 4.12% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest JNJ Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Daniel Sparks
The Motley Fool
BuyInitiates Coverage
-
Michael Nedelcovych
TD Cowen
BuyMaintains
$250.00 → $300.00
Kinjel Shah
Zacks Equity Research
BuyInitiates Coverage
-
Trung Huynh
RBC Capital
BuyMaintains
$265.00 → $287.00
Bazziggr
StockTwits
BuyInitiates Coverage
-
Adria Cimino
The Motley Fool
BuyInitiates Coverage
-
Jason Gerberry
BofA Securities
HoldReiterates
$254.00 → $263.00
Larry Biegelsen
Wells Fargo
BuyReiterates
$263.00
UK
Investing.com
BuyInitiates Coverage
-
Asad Haider
Goldman Sachs
BuyReiterates
$265.00 → $275.00
Joanne Wuensch
Citi
BuyReiterates
$285.00 → $298.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Terence Flynn
Morgan Stanley
BuyMaintains
$283.00 → $284.00
Chris Schott
JP Morgan
HoldMaintains
$260.00
Morten Herholdt
HSBC
BuyMaintains
$280.00 → $290.00
James Halley
The Motley Fool
BuyInitiates Coverage
-
Larry Biegelsen
Wells Fargo
BuyMaintains
$263.00
Vamil Divan
Guggenheim
BuyReiterates
$244.88 → $270.00
Asad Haider
Goldman Sachs
BuyMaintains
$265.00 → $275.00
Louise Chen
Scotiabank
BuyMaintains
$265.00
Vamil Divan
Guggenheim
BuyMaintains
$266.00
Jason Gerberry
BofA Securities
HoldMaintains
$254.00
Michael Nedelcovych
TD Cowen
BuyMaintains
$250.00
David Risinger
Leerink Partners
BuyReiterates
$265.00
Matt Miksic
Barclays
HoldReiterates
$255.00
David Risinger
Leerink Partners
BuyReiterates
$265.00
Matt Miksic
Barclays
HoldReiterates
$255.00
Hans Engel
Erste
BuyMaintains
-
Hans Engel
Erste
BuyMaintains
-
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Google Drug Manufacturers - General
TipRanks - Google
BuyReiterates
$250.00 → $252.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$260.00 → $264.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
BuyReiterates
$252.00 → $258.00
xAi Drug Manufacturers - General
TipRanks - xAI
HoldReiterates
$241.00 → $240.00
Joanne Wuensch
Citi
BuyReiterates
$285.00

Frequently Asked Questions

What is the analyst consensus rating for JNJ?

The analyst consensus rating for JNJ is "Buy" based on 25 analyst recommendations.

What is the average price target for JNJ?

The average 12-month price target for JNJ is $269.94, representing an upside of 4.1% from the current price of $259.27.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.